Breathing Easier: How Aficamten is Giving New Hope to HCM Patients

In this episode, we dive into the lives of patients with hypertrophic cardiomyopathy (HCM) and how Aficamten is offering them hope for a better future. From breathing easier to avoiding surgery, we’ll uncover the real impact of this new treatment backed by the SEQUOIA-HCM trial. If you care about heart health or know someone living with HCM, this one’s for you.

Links to the Podcast

• Apple Podcast:⁠⁠Listen on Apple Podcast⁠⁠
• Spotify:⁠⁠Listen on Spotify⁠⁠
• Amazon Music:⁠⁠Listen on Amazon Music⁠⁠
• YouTube:⁠⁠Watch on YouTube⁠⁠

📝Source:

Study Title: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM Trial)

Publication Date: May 13, 2024

NEJM.org - SEQUOIA-HCM Trial

🔗Full Study Details:NEJM - SEQUOIA-HCM Study
🔗ClinicalTrials.gov:SEQUOIA-HCM NCT05186818

#BreathingEasier #HeartHealth #Aficamten #NewHope #SEQUOIAHCM #CardiologyTalk #Podcast #RealImpact #MedicalBreakthroughs #BetterLiving